
Carol M. Koslow
Examiner (ID: 12920, Phone: (571)272-1371 , Office: P/1734 )
| Most Active Art Unit | 1734 |
| Art Unit(s) | 1734, 1754, 1793, 1755, 1108 |
| Total Applications | 5011 |
| Issued Applications | 4022 |
| Pending Applications | 258 |
| Abandoned Applications | 784 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11625906
[patent_doc_number] => 20170136095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-18
[patent_title] => 'Methods of Treatment Using A Pentapeptide Derived From The C-Terminus Of Glucagon-Like Peptide 1 (GLP-1)'
[patent_app_type] => utility
[patent_app_number] => 15/410703
[patent_app_country] => US
[patent_app_date] => 2017-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 14404
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15410703
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/410703 | Methods of treatment using a pentapeptide derived from the C-Terminus of Glucagon-Like Peptide 1 (GLP-1) | Jan 18, 2017 | Issued |
Array
(
[id] => 14309641
[patent_doc_number] => 20190144524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => FACTOR VIII VARIANTS, NUCLEIC ACID SEQUENCES, AND METHODS AND USES FOR TREATMENT OF HEMOSTASIS DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/069778
[patent_app_country] => US
[patent_app_date] => 2017-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23993
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16069778
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/069778 | FACTOR VIII VARIANTS, NUCLEIC ACID SEQUENCES, AND METHODS AND USES FOR TREATMENT OF HEMOSTASIS DISORDERS | Jan 12, 2017 | Pending |
Array
(
[id] => 15163283
[patent_doc_number] => 10487121
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-26
[patent_title] => D-peptide inhibitors of HIV entry and methods of use
[patent_app_type] => utility
[patent_app_number] => 16/068306
[patent_app_country] => US
[patent_app_date] => 2017-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 22277
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16068306
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/068306 | D-peptide inhibitors of HIV entry and methods of use | Jan 5, 2017 | Issued |
Array
(
[id] => 13826535
[patent_doc_number] => 20190016752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => POLY(AMINO ACID), PROTEIN-POLY(AMINO ACID) CONJUGATE AND PREPARATION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/067022
[patent_app_country] => US
[patent_app_date] => 2016-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13918
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16067022
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/067022 | POLY(AMINO ACID), PROTEIN-POLY(AMINO ACID) CONJUGATE AND PREPARATION METHOD THEREOF | Dec 29, 2016 | Pending |
Array
(
[id] => 11942085
[patent_doc_number] => 20170246236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'METHODS AND COMPOSITIONS FOR ENHANCED DELIVERY OF COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/376321
[patent_app_country] => US
[patent_app_date] => 2016-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 53483
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15376321
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/376321 | METHODS AND COMPOSITIONS FOR ENHANCED DELIVERY OF COMPOUNDS | Dec 11, 2016 | Abandoned |
Array
(
[id] => 11514294
[patent_doc_number] => 20170081368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-23
[patent_title] => 'PEPTIDES AS OXYTOCIN AGONISTS'
[patent_app_type] => utility
[patent_app_number] => 15/368902
[patent_app_country] => US
[patent_app_date] => 2016-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5799
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15368902
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/368902 | PEPTIDES AS OXYTOCIN AGONISTS | Dec 4, 2016 | Abandoned |
Array
(
[id] => 13618843
[patent_doc_number] => 20180360973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => PROTEIN CONJUGATE USING A FATTY ACID DERIVATIVE AND METHOD FOR PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/780934
[patent_app_country] => US
[patent_app_date] => 2016-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10433
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15780934
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/780934 | PROTEIN CONJUGATE USING A FATTY ACID DERIVATIVE AND METHOD FOR PREPARATION THEREOF | Dec 1, 2016 | Abandoned |
Array
(
[id] => 11670029
[patent_doc_number] => 20170158748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'GLUCOSE-REGULATING POLYPEPTIDES AND METHODS OF MAKING AND USING SAME'
[patent_app_type] => utility
[patent_app_number] => 15/365792
[patent_app_country] => US
[patent_app_date] => 2016-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 70733
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15365792
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/365792 | Glucose-regulating polypeptides and methods of making and using same | Nov 29, 2016 | Issued |
Array
(
[id] => 13729715
[patent_doc_number] => 20180369325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => COMPOUNDS AND METHODS FOR TREATING METABOLIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 15/777510
[patent_app_country] => US
[patent_app_date] => 2016-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12989
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15777510
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/777510 | COMPOUNDS AND METHODS FOR TREATING METABOLIC DISORDERS | Nov 17, 2016 | Abandoned |
Array
(
[id] => 13957881
[patent_doc_number] => 20190055284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => WATER-SOLUBLE RAPAMYCIN DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 15/553088
[patent_app_country] => US
[patent_app_date] => 2016-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11549
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15553088
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/553088 | Water-soluble rapamycin derivatives | Nov 8, 2016 | Issued |
Array
(
[id] => 11618430
[patent_doc_number] => 20170128617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-11
[patent_title] => 'SEALANT FORMULATION AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/345722
[patent_app_country] => US
[patent_app_date] => 2016-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7628
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15345722
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/345722 | SEALANT FORMULATION AND USES THEREOF | Nov 7, 2016 | Abandoned |
Array
(
[id] => 14043467
[patent_doc_number] => 20190077840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => SELECTIVE MCL-1 BINDING PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 15/772226
[patent_app_country] => US
[patent_app_date] => 2016-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12854
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15772226
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/772226 | SELECTIVE MCL-1 BINDING PEPTIDES | Oct 27, 2016 | Abandoned |
Array
(
[id] => 11443192
[patent_doc_number] => 20170044213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-16
[patent_title] => 'METHOD FOR IDENTIFYING NOVEL MINOR HISTOCOMPATIBILITY ANTIGENS'
[patent_app_type] => utility
[patent_app_number] => 15/299387
[patent_app_country] => US
[patent_app_date] => 2016-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 30115
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15299387
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/299387 | Method for identifying novel minor histocompatibility antigens | Oct 19, 2016 | Issued |
Array
(
[id] => 13521999
[patent_doc_number] => 20180312542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => ENDOSOMAL ESCAPE PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 15/767842
[patent_app_country] => US
[patent_app_date] => 2016-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22810
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15767842
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/767842 | ENDOSOMAL ESCAPE PEPTIDES | Oct 18, 2016 | Abandoned |
Array
(
[id] => 13151843
[patent_doc_number] => 10092625
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-09
[patent_title] => Liquid enteral nutritional composition with a low monovalent metal ion content
[patent_app_type] => utility
[patent_app_number] => 15/295484
[patent_app_country] => US
[patent_app_date] => 2016-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10625
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15295484
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/295484 | Liquid enteral nutritional composition with a low monovalent metal ion content | Oct 16, 2016 | Issued |
Array
(
[id] => 11901914
[patent_doc_number] => 09771337
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-26
[patent_title] => 'Neprilysin inhibitors'
[patent_app_type] => utility
[patent_app_number] => 15/289356
[patent_app_country] => US
[patent_app_date] => 2016-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33570
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15289356
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/289356 | Neprilysin inhibitors | Oct 9, 2016 | Issued |
Array
(
[id] => 11512920
[patent_doc_number] => 20170079993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-23
[patent_title] => 'LIPID COMPOSITIONS WITH HIGH DHA CONTENT'
[patent_app_type] => utility
[patent_app_number] => 15/283971
[patent_app_country] => US
[patent_app_date] => 2016-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 19183
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15283971
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/283971 | Lipid compositions with high DHA content | Oct 2, 2016 | Issued |
Array
(
[id] => 13328505
[patent_doc_number] => 20180215790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => METHOD OF TREATING MELANOCORTIN-4 RECEPTOR PATHWAY-ASSOCIATED DISORDERS
[patent_app_type] => utility
[patent_app_number] => 15/764730
[patent_app_country] => US
[patent_app_date] => 2016-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15493
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15764730
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/764730 | METHOD OF TREATING MELANOCORTIN-4 RECEPTOR PATHWAY-ASSOCIATED DISORDERS | Sep 28, 2016 | Pending |
Array
(
[id] => 15145065
[patent_doc_number] => 20190351010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => CYCLIC POLYPEPTIDE FOR THE TREATMENT OF PHA TYPE 1B
[patent_app_type] => utility
[patent_app_number] => 15/760042
[patent_app_country] => US
[patent_app_date] => 2016-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8106
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15760042
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/760042 | CYCLIC POLYPEPTIDE FOR THE TREATMENT OF PHA TYPE 1B | Sep 13, 2016 | Pending |
Array
(
[id] => 13399917
[patent_doc_number] => 20180251501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => Molded Article and Method for Producing Molded Article
[patent_app_type] => utility
[patent_app_number] => 15/760492
[patent_app_country] => US
[patent_app_date] => 2016-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6120
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15760492
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/760492 | Molded Article and Method for Producing Molded Article | Sep 7, 2016 | Abandoned |